This is a table of type bigram and their frequencies. Use it to search & browse the list to learn more about your study carrel.
bigram | frequency |
---|---|
particle size | 393 |
virus particles | 219 |
like particles | 208 |
flow rate | 194 |
particle concentration | 168 |
particle deposition | 155 |
size distribution | 153 |
electron microscopy | 152 |
air filter | 151 |
surgical smoke | 137 |
particle diameter | 128 |
nanotrap particles | 124 |
pressure drop | 124 |
influenza virus | 120 |
airborne microorganisms | 110 |
air quality | 106 |
particle number | 105 |
indoor air | 102 |
respiratory tract | 101 |
airborne particles | 98 |
air pollution | 95 |
airborne transmission | 89 |
defective interfering | 89 |
nt particles | 84 |
indoor environments | 84 |
particle counter | 83 |
viral rna | 82 |
air velocity | 81 |
filter paper | 79 |
viral particles | 76 |
cord uid | 76 |
doc id | 76 |
particle transport | 75 |
aerosol particles | 72 |
hepa filter | 72 |
gene therapy | 72 |
thin sections | 71 |
health effects | 71 |
fine particles | 71 |
particle distribution | 71 |
spherical particles | 69 |
negative stain | 69 |
vlp vaccines | 69 |
negative staining | 67 |
size range | 66 |
immune response | 66 |
respiratory syndrome | 63 |
particle sizes | 62 |
larger particles | 62 |
sampling volume | 62 |
indoor environment | 61 |
negatively stained | 60 |
particulate matter | 60 |
room temperature | 58 |
airborne particle | 58 |
filter media | 57 |
relative humidity | 56 |
air conditioning | 55 |
cell culture | 55 |
collection efficiency | 55 |
stain iem | 53 |
acute respiratory | 53 |
smaller particles | 53 |
small particles | 53 |
drug delivery | 52 |
like particle | 52 |
droplet nuclei | 52 |
experimental data | 51 |
particle concentrations | 51 |
airborne bacteria | 50 |
surface area | 50 |
air filters | 50 |
bioaerosol sampling | 49 |
nucleic acids | 49 |
gene delivery | 49 |
oxidative stress | 49 |
interfering particles | 49 |
sampling tube | 48 |
surgical mask | 48 |
ultrafine particles | 48 |
air flow | 48 |
deposition velocity | 47 |
public health | 47 |
spray drying | 47 |
flow field | 47 |
negative mobility | 46 |
outdoor air | 46 |
particle load | 46 |
number concentration | 45 |
capsid protein | 45 |
sampling flow | 44 |
particle formation | 44 |
standard deviation | 43 |
ambient air | 43 |
air exchange | 42 |
severe acute | 42 |
particle counting | 42 |
operating room | 42 |
turbulent flow | 41 |
bioaerosol sampler | 41 |
ellipsoidal particles | 40 |
health care | 40 |
flow rates | 40 |
particles will | 39 |
escherichia coli | 39 |
exhaled breath | 39 |
aerodynamic diameter | 39 |
sized particles | 39 |
quantum dots | 38 |
air cleaning | 38 |
particle mass | 38 |
particles may | 37 |
nanocomposite microparticles | 37 |
nucleic acid | 36 |
loss rate | 36 |
deposition rate | 36 |
infected cells | 36 |
size distributions | 36 |
particle loss | 36 |
aspect ratio | 36 |
minimum sampling | 35 |
bioaerosol particles | 35 |
carbon nanotubes | 35 |
electrostatic cleaner | 35 |
displacement ventilation | 35 |
particle penetration | 34 |
filter cake | 34 |
particle group | 34 |
filtration velocity | 34 |
may also | 34 |
per unit | 34 |
two different | 34 |
epithelial cells | 34 |
filtration efficiency | 34 |
aerosol transmission | 33 |
particles per | 33 |
plaque assays | 33 |
immune responses | 33 |
fungal spores | 33 |
widely used | 33 |
thermal plume | 32 |
disease virus | 32 |
electric field | 32 |
without nt | 32 |
dv flow | 32 |
air supply | 32 |
behind bends | 32 |
permeate flux | 31 |
pfu ml | 31 |
settling velocity | 31 |
average diameter | 31 |
viral genomes | 31 |
exhaled air | 30 |
fluid interfaces | 30 |
particle counts | 30 |
exhaled particles | 30 |
membrane adsorbers | 30 |
particle sizer | 30 |
particle surface | 30 |
viral dna | 30 |
gene transfer | 30 |
infectious diseases | 29 |
isokinetic sampling | 29 |
surgical masks | 29 |
boundary conditions | 29 |
commonly used | 29 |
vlp vaccine | 29 |
large particles | 29 |
membrane filtration | 29 |
air purifier | 29 |
boundary layer | 29 |
particle dispersion | 28 |
human health | 28 |
mass concentration | 28 |
molecular weight | 28 |
clinical trials | 27 |
spherical particle | 27 |
tidal breathing | 27 |
coulter counter | 27 |
aerosol transport | 27 |
buoyant flow | 27 |
deposited particles | 27 |
livestock production | 27 |
even though | 27 |
straight duct | 27 |
normal distribution | 27 |
previous studies | 27 |
production systems | 27 |
aspect ratios | 27 |
total particle | 26 |
sampling time | 26 |
biological decay | 26 |
encephalitis virus | 26 |
air cleanliness | 26 |
disease transmission | 26 |
dust particles | 26 |
conditioning system | 26 |
negatively charged | 26 |
deposition ratio | 26 |
surface charge | 26 |
indoor particle | 25 |
bioaerosol samplers | 25 |
systematic review | 25 |
present study | 25 |
interface deformations | 25 |
aerosol particle | 25 |
friction coefficient | 25 |
statistically significant | 25 |
cell cultures | 25 |
silica nanoparticles | 25 |
coarse particles | 25 |
protective equipment | 25 |
aerosol deposition | 25 |
different types | 25 |
numerical simulation | 25 |
activated carbon | 24 |
measured using | 24 |
influenza viruses | 24 |
optofluidic platform | 24 |
human papillomavirus | 24 |
biological effects | 24 |
aerosol formation | 24 |
airborne pathogens | 24 |
flow cytometry | 24 |
therapy vectors | 24 |
much larger | 24 |
light scattering | 24 |
influenza vaccine | 24 |
particle density | 24 |
aerosol containment | 23 |
mouth disease | 23 |
fever virus | 23 |
united states | 23 |
ventilation systems | 23 |
dust collecting | 23 |
cough velocity | 23 |
important role | 23 |
fluid dynamics | 23 |
total number | 23 |
filter material | 23 |
commercially available | 23 |
dendritic cells | 23 |
brownian diffusion | 23 |
laminar flow | 23 |
isoelectric point | 23 |
airborne viruses | 23 |
outdoor particles | 23 |
personal protective | 23 |
infection control | 23 |
particle counters | 22 |
size ranges | 22 |
time step | 22 |
delivery system | 22 |
flow velocity | 22 |
inhaled dose | 22 |
lung cancer | 22 |
three times | 22 |
laser ablation | 22 |
viral proteins | 22 |
gravitational settling | 22 |
delta inulin | 22 |
poisson distribution | 22 |
thin section | 22 |
air change | 22 |
airflow rate | 22 |
respiratory diseases | 22 |
per liter | 22 |
droplet size | 22 |
lognormal distribution | 22 |
deposition rates | 22 |
dust holding | 22 |
particles generated | 21 |
filtration efficiencies | 21 |
breathing zone | 21 |
human respiratory | 21 |
number concentrations | 21 |
test chamber | 21 |
several studies | 21 |
computational fluid | 21 |
mechanical ventilation | 21 |
rift valley | 21 |
virus particle | 21 |
particle count | 21 |
high concentrations | 21 |
virus infection | 21 |
mediated interactions | 21 |
amino acid | 21 |
particle trajectories | 21 |
expression systems | 21 |
rna viruses | 21 |
large number | 21 |
vesicular stomatitis | 21 |
viral vectors | 21 |
protein nanoparticles | 21 |
indoor bioaerosol | 21 |
respiratory droplets | 21 |
mass flow | 21 |
high efficiency | 21 |
airborne infection | 21 |
defective viral | 21 |
holding capacity | 21 |
human subjects | 21 |
water content | 21 |
contact angle | 21 |
host cell | 21 |
electron microscope | 20 |
capillary interactions | 20 |
laf system | 20 |
aerosolized particles | 20 |
chain reaction | 20 |
stomatitis virus | 20 |
nanotrap particle | 20 |
expression system | 20 |
exposure assessment | 20 |
niflumic acid | 20 |
electrostatic interactions | 20 |
current study | 20 |
cell lines | 20 |
glass fiber | 20 |
air sampling | 20 |
valley fever | 20 |
avian influenza | 20 |
sendai virus | 20 |
chemical composition | 20 |
respiratory infections | 20 |
ventilation system | 20 |
respiratory viruses | 20 |
adverse health | 20 |
mass spectrometry | 20 |
respiratory system | 20 |
hepa filters | 19 |
eulerian model | 19 |
remain suspended | 19 |
mg ml | 19 |
respiratory protection | 19 |
drag coefficient | 19 |
pore size | 19 |
particles larger | 19 |
ward cubicle | 19 |
nm particles | 19 |
interfering rnas | 19 |
eddy simulation | 19 |
present work | 19 |
particulate air | 19 |
immune system | 19 |
fibrous filter | 19 |
type i | 19 |
per hour | 19 |
aerosol generation | 19 |
human body | 19 |
syncytial virus | 19 |
vaccine delivery | 19 |
experimental results | 19 |
positively charged | 19 |
particle generation | 19 |
kinetic energy | 19 |
wide range | 19 |
polymerase chain | 19 |
aerodynamic particle | 19 |
alveolar region | 19 |
surgical suite | 19 |
infectious disease | 19 |
respiratory syncytial | 19 |
bacterial cells | 19 |
counting efficiency | 19 |
two types | 19 |
cloth masks | 18 |
efficiency air | 18 |
virus transmission | 18 |
particles deposited | 18 |
recent years | 18 |
viral genome | 18 |
dental procedures | 18 |
new particle | 18 |
rights reserved | 18 |
distribution curve | 18 |
laf group | 18 |
organic compounds | 18 |
mm particles | 18 |
titanium dioxide | 18 |
lagrangian approach | 18 |
environmental conditions | 18 |
production processes | 18 |
healthcare workers | 18 |
plasmid dna | 18 |
pollution source | 18 |
bovine serum | 18 |
dynamic parameters | 18 |
airborne dust | 18 |
high concentration | 18 |
infectious particles | 18 |
particle separation | 18 |
aerosol technology | 18 |
delivery systems | 18 |
glass fibrous | 18 |
will also | 18 |
ion emission | 18 |
infectious dose | 18 |
crystalline silica | 18 |
flow patterns | 18 |
particle detection | 18 |
frequency distribution | 18 |
contact line | 18 |
adhesion strength | 18 |
primary particles | 18 |
national institute | 18 |
pig houses | 18 |
cleaning technology | 17 |
average particle | 17 |
viral titers | 17 |
wrapped states | 17 |
face masks | 17 |
fluid flow | 17 |
small round | 17 |
expiratory flow | 17 |
experimental setup | 17 |
door openings | 17 |
membrane surface | 17 |
term exposure | 17 |
aerosol box | 17 |
venezuelan equine | 17 |
two particles | 17 |
deposition loss | 17 |
lipid bilayer | 17 |
clay minerals | 17 |
colloidal particles | 17 |
recent study | 17 |
steady state | 17 |
human lung | 17 |
concentration degree | 17 |
particles smaller | 17 |
viral infections | 17 |
immunodeficiency virus | 17 |
particles produced | 17 |
change rate | 17 |
diameter less | 17 |
exhaled jet | 17 |
natural ventilation | 17 |
large eddy | 17 |
viable virus | 17 |
submicron particles | 17 |
penetration coefficient | 17 |
much higher | 16 |
interfering rna | 16 |
lower limit | 16 |
indoor bioaerosols | 16 |
suspended particles | 16 |
occupational safety | 16 |
may cause | 16 |
personal samplers | 16 |
viral replication | 16 |
animal houses | 16 |
aerosol dispersion | 16 |
fully developed | 16 |
atmospheric dust | 16 |
sectional area | 16 |
air circulation | 16 |
built environment | 16 |
relaxation time | 16 |
structural proteins | 16 |
reference building | 16 |
direct contact | 16 |
sampling devices | 16 |
nm diameter | 16 |
particle diameters | 16 |
high flow | 16 |
velocity maps | 16 |
virus defective | 16 |
bacterial contamination | 16 |
light microscopy | 16 |
coal combustion | 16 |
vaccine adjuvants | 16 |
geometric mean | 16 |
three different | 16 |
equine encephalitis | 16 |
cross section | 16 |
cell responses | 16 |
particle shape | 16 |
biological interfaces | 16 |
particle removal | 16 |
also used | 16 |
boundary condition | 16 |
optical particle | 15 |
human blood | 15 |
human immunodeficiency | 15 |
agar plates | 15 |
dv system | 15 |
ventilated rooms | 15 |
mask design | 15 |
adjuvant activity | 15 |
high temperature | 15 |
coronavirus disease | 15 |
upper airways | 15 |
negative bacteria | 15 |
lymph nodes | 15 |
exposed person | 15 |
occupational exposure | 15 |
chemical reaction | 15 |
airborne bacterial | 15 |
per minute | 15 |
membrane filter | 15 |
face coverings | 15 |
recent studies | 15 |
small molecules | 15 |
particles within | 15 |
creative commons | 15 |
virus type | 15 |
inertial impaction | 15 |
nc particles | 15 |
jc virus | 15 |
clinical trial | 15 |
parent virus | 15 |
transition metals | 15 |
particle velocity | 15 |
separation velocity | 15 |
stained preparations | 15 |
contact angles | 15 |
structural protein | 15 |
airflow velocity | 15 |
device use | 15 |
average concentration | 15 |
calculated using | 15 |
size particles | 15 |
aerosol samplers | 15 |
two times | 15 |
mesoporous silica | 15 |
time points | 15 |
mm diameter | 15 |
first stage | 15 |
infected individuals | 15 |
relatively high | 15 |
outdoor particle | 15 |
sampling velocity | 15 |
distilled water | 15 |
air ions | 15 |
particles emitted | 15 |
air flows | 14 |
livestock houses | 14 |
personal exposure | 14 |
surrounding air | 14 |
plaque assay | 14 |
gm ml | 14 |
lm particles | 14 |
infectious agents | 14 |
supply air | 14 |
environmental factors | 14 |
risk assessment | 14 |
diffusion coefficient | 14 |
control volume | 14 |
adv particles | 14 |
fibrous layer | 14 |
likely due | 14 |
will increase | 14 |
statistical modelling | 14 |
infection risk | 14 |
significant difference | 14 |
concentration field | 14 |
whole virus | 14 |
different sizes | 14 |
respiratory activities | 14 |
directed velocity | 14 |
airflow pattern | 14 |
flux model | 14 |
tangential flow | 14 |
time detection | 14 |
tracheal intubation | 14 |
results show | 14 |
chemical society | 14 |
tissue culture | 14 |
opening windows | 14 |
immune electron | 14 |
flow filtration | 14 |
working environment | 14 |
positive pressure | 14 |
downstream processing | 14 |
biological particles | 14 |
dental offices | 14 |
much smaller | 14 |
particle exposure | 14 |
particulate matters | 14 |
humic substances | 14 |
particle phase | 14 |
cleanliness level | 14 |
surface projections | 14 |
upper respiratory | 14 |
concentration distribution | 14 |
cystic fibrosis | 14 |
following expression | 14 |
american chemical | 14 |
containment devices | 14 |
story building | 13 |
airborne microbial | 13 |
herpesvirus particles | 13 |
indoor airflow | 13 |
particle tracking | 13 |
deposition efficiency | 13 |
surgical flow | 13 |
also called | 13 |
clinical samples | 13 |
correction coefficient | 13 |
unit operations | 13 |
cell line | 13 |
mycobacterium tuberculosis | 13 |
fecal extracts | 13 |
staphylococcus aureus | 13 |
ionic strength | 13 |
aerosol exposure | 13 |
healthy human | 13 |
unidirectional flow | 13 |
aerosol concentrations | 13 |
size bins | 13 |
porous media | 13 |
volatile organic | 13 |
infected animals | 13 |
charged particles | 13 |
particle motion | 13 |
size reduction | 13 |
flow cleanroom | 13 |
infection index | 13 |
cell surface | 13 |
ventilation rate | 13 |
particles remain | 13 |
efficiency particulate | 13 |
novel coronavirus | 13 |
significantly higher | 13 |
generated particles | 13 |
unstructured grids | 13 |
cellular uptake | 13 |
virus isolation | 13 |
results indicate | 13 |
rna extraction | 13 |
organic materials | 13 |
reynolds number | 13 |
poultry houses | 13 |
much less | 13 |
exchange rates | 13 |
average value | 13 |
semliki forest | 13 |
particle vaccine | 13 |
samples without | 13 |
syndrome virus | 13 |
bacterial concentration | 13 |
time pcr | 13 |
large numbers | 13 |
fusion protein | 13 |
may result | 13 |
pilot study | 13 |
high velocity | 13 |
health risk | 13 |
viral load | 13 |
viral transmission | 13 |
hong kong | 13 |
data analysis | 13 |
blood cell | 13 |
middle east | 13 |
large sampling | 13 |
recombinant protein | 13 |
performed using | 13 |
turbulent kinetic | 13 |
presenting cells | 13 |
risk factors | 13 |
lagrangian model | 13 |
often used | 13 |
pandemic influenza | 13 |
laf area | 13 |
norwalk agent | 13 |
particles containing | 13 |
dust explosion | 13 |
new york | 13 |
ansys fluent | 13 |
exposure limits | 12 |
aerosol sampler | 12 |
infected patients | 12 |
vaccinia virus | 12 |
turbulent flows | 12 |
numerical simulations | 12 |
syndrome coronavirus | 12 |
viral particle | 12 |
fine particle | 12 |
usually used | 12 |
wide variety | 12 |
membrane tension | 12 |
hydrogen peroxide | 12 |
per second | 12 |
induced deposition | 12 |
brownian force | 12 |
carbon dioxide | 12 |
laser beam | 12 |
life expectancy | 12 |
airflow simulation | 12 |
copyright holder | 12 |
vlp antibodies | 12 |
particles less | 12 |
van der | 12 |
der waals | 12 |
ablated particles | 12 |
endoplasmic reticulum | 12 |
pulsed laser | 12 |
wrapped state | 12 |
water vapor | 12 |
particle behavior | 12 |
sampling error | 12 |
red blood | 12 |
sampling device | 12 |
slightly larger | 12 |
human exhaled | 12 |
colloid particles | 12 |
affinity chromatography | 12 |
moisture content | 12 |
ebola virus | 12 |
serum albumin | 12 |
air samples | 12 |
solid particles | 12 |
bsa molecules | 12 |
will cause | 12 |
cell membrane | 12 |
gas phase | 12 |
vlp surface | 12 |
diameter larger | 12 |
mammalian cells | 12 |
approximately nm | 12 |
enveloped viruses | 12 |
vero cells | 12 |
displacement ventilated | 12 |
static bias | 12 |
scanning mobility | 12 |
source location | 12 |
east respiratory | 12 |
immune complexes | 12 |
lower floors | 12 |
forest virus | 12 |
particle interactions | 12 |
chemical conjugation | 12 |
aerosol concentration | 12 |
capsid proteins | 12 |
care workers | 12 |
particles formed | 12 |
janus particles | 12 |
breathing level | 12 |
nanosized particles | 12 |
ventilated room | 12 |
thin sectioning | 12 |
room air | 12 |
persistent infection | 12 |
health hazards | 12 |
indoor aerosol | 12 |
genetic engineering | 12 |
following equation | 12 |
mass fraction | 12 |
air distribution | 12 |
target virus | 12 |
human influenza | 12 |
mediated endocytosis | 12 |
per cubic | 12 |
numerical study | 12 |
residence time | 12 |
adhesion strengths | 12 |
breathing cycle | 12 |
operating theatres | 12 |
particle growth | 12 |
preliminary study | 12 |
sample preparation | 12 |
frequently used | 12 |
aerosolized viral | 12 |
fluorescence microscopy | 12 |
turbulence model | 12 |
active sampling | 12 |
antibody molecules | 12 |
mobility particle | 12 |
different particle | 12 |
higher particle | 12 |
vaccine development | 12 |
centrifugal force | 12 |
diameter range | 12 |
cylindrical particles | 12 |
drag force | 12 |
particles released | 12 |
supply flow | 12 |
helper virus | 12 |
alveolar wall | 12 |
infection prevention | 12 |
lower respiratory | 12 |
particles cm | 12 |
airborne microbes | 12 |
without air | 11 |
deformation energy | 11 |
dust concentrations | 11 |
nt particle | 11 |
total dust | 11 |
drying process | 11 |
hand side | 11 |
particle numbers | 11 |
mask designs | 11 |
droplets expelled | 11 |
antibody concentration | 11 |
fl signals | 11 |
temperature difference | 11 |
particles ranging | 11 |
biological activity | 11 |
particle image | 11 |
human activities | 11 |
boiling point | 11 |
viral infection | 11 |
peer review | 11 |
brain barrier | 11 |
particle capture | 11 |
individual particles | 11 |
around nm | 11 |
may affect | 11 |
surface properties | 11 |
sampling methods | 11 |
geometric parameters | 11 |
time period | 11 |
cigarette smoke | 11 |
air phase | 11 |
silver nanoparticles | 11 |
force acting | 11 |
breath shields | 11 |
oxide nanoparticles | 11 |
premature mortality | 11 |
source apportionment | 11 |
exhaust grilles | 11 |
viral gene | 11 |
also known | 11 |
quantitative analysis | 11 |
glass barriers | 11 |
relatively low | 11 |
bacterial bioaerosols | 11 |
deposition amount | 11 |
quantitative pcr | 11 |
ionization electrode | 11 |
japanese encephalitis | 11 |
face velocity | 11 |
ion exchange | 11 |
authors declare | 11 |
also present | 11 |
particle spread | 11 |
veev capsid | 11 |
bacillus subtilis | 11 |
pressure difference | 11 |
velocity field | 11 |
world health | 11 |
exhaled droplets | 11 |
dry powder | 11 |
sampling period | 11 |
aerosol science | 11 |
negative pressure | 11 |
image analysis | 11 |
refractive index | 11 |
mechanically ventilated | 11 |
cell death | 11 |
viral infectivity | 11 |
particle radius | 11 |
strongly influenced | 11 |
governing equations | 11 |
vaccine production | 11 |
round particles | 11 |
slip correction | 11 |
material balance | 11 |
measles virus | 11 |
deposition onto | 11 |
cell dna | 11 |
indoor airborne | 11 |
pulmonary disease | 11 |
contaminant transport | 11 |
physicochemical properties | 11 |
indication value | 11 |
particles resembling | 11 |
porcine reproductive | 11 |
measured data | 11 |
wall deposits | 11 |
cell counting | 11 |
sealed box | 11 |
upper floors | 11 |
major role | 11 |
small sampling | 11 |
human exposure | 11 |
fluorescence intensity | 11 |
deposition behind | 11 |
fiber filter | 11 |
breast cancer | 11 |
nlrp inflammasome | 11 |
probability graph | 11 |
experimental study | 11 |
mg kg | 11 |
surface chemistry | 11 |
antibody binding | 11 |
surface antigen | 11 |
results obtained | 11 |
growth rates | 11 |
blood cells | 11 |
thermal plumes | 11 |
health organization | 11 |
exchange rate | 11 |
different size | 11 |
face mask | 11 |
enhancement deposition | 11 |
steady modeling | 11 |
brownian motion | 11 |
base case | 11 |
case study | 11 |
online supplementary | 11 |
influenza vaccines | 11 |
shear forces | 10 |
protective immunity | 10 |
transient modeling | 10 |
airborne dispersion | 10 |
top orientation | 10 |
aerodynamic size | 10 |
ophthalmic examination | 10 |
strong immune | 10 |
rare earth | 10 |
microfluidic rps | 10 |
temperature gradient | 10 |
granted medrxiv | 10 |
gel electrophoresis | 10 |
innate immune | 10 |
ambient particles | 10 |
highly sensitive | 10 |
calu cells | 10 |
put forward | 10 |
upper acini | 10 |
micron particles | 10 |
associated virus | 10 |
author funder | 10 |
high levels | 10 |
vaccine efficacy | 10 |
mobility effect | 10 |
corona discharge | 10 |
particles collected | 10 |
particle relaxation | 10 |
solid surfaces | 10 |
stoichiometric estimates | 10 |
endosomal escape | 10 |
tensile strength | 10 |
counting methods | 10 |
electrostatic precipitator | 10 |
viral shedding | 10 |
membrane area | 10 |
floor level | 10 |
electrostatic forces | 10 |
dimensionless distance | 10 |
cancer cells | 10 |
diphtheria toxoid | 10 |
ventilation ducts | 10 |
respirable fraction | 10 |
air density | 10 |
separating distance | 10 |
airborne contamination | 10 |
target cell | 10 |
linearly proportional | 10 |
graph paper | 10 |
social distancing | 10 |
penetration coefficients | 10 |
intensive care | 10 |
microbial communities | 10 |
aerosol sampling | 10 |
particle trajectory | 10 |
cfd model | 10 |
several tens | 10 |
eulerian approach | 10 |
air pollutants | 10 |
electrostatic precipitation | 10 |
safety issues | 10 |
engineered nanoparticles | 10 |
early stage | 10 |
surface contamination | 10 |
microporous membrane | 10 |
transition periods | 10 |
particle maps | 10 |
recombinant proteins | 10 |
modeling particle | 10 |
emission sources | 10 |
whole human | 10 |
additional resistance | 10 |
bacterial pathogens | 10 |
samples collected | 10 |
dust collector | 10 |
section iem | 10 |
reactive red | 10 |
colony counting | 10 |
respirable crystalline | 10 |
microbial contamination | 10 |
long distance | 10 |
line tension | 10 |
aerosols generated | 10 |
similar particles | 10 |
also shown | 10 |
viral inactivation | 10 |
droplets generated | 10 |
expiratory droplets | 10 |
collection substrate | 10 |
sodium chloride | 10 |
filtration area | 10 |
generate ros | 10 |
three types | 10 |
correction factor | 10 |
tube length | 10 |
larger particle | 10 |
room ventilation | 10 |
settle plates | 10 |
pulmonary diseases | 10 |
mean diameter | 10 |
capillary forces | 10 |
environment measurement | 10 |
operating conditions | 10 |
respiratory virus | 10 |
capillary interaction | 10 |
humoral immune | 10 |
infectious virus | 10 |
close proximity | 10 |
turbulence models | 10 |
capture velocity | 10 |
adenoviral vectors | 10 |
experimental conditions | 10 |
vortex ring | 10 |
carbon black | 10 |
operating theatre | 10 |
washed times | 10 |
potential health | 10 |
whole blood | 10 |
electron microscopic | 10 |
healthy individuals | 10 |
normalized concentration | 10 |
filtration performance | 10 |
fiber diameter | 10 |
collecting plate | 10 |
cmp wastewater | 10 |
mouth opening | 10 |
viral diseases | 10 |
jet propagation | 10 |
bacterial bioaerosol | 10 |
peak expiratory | 10 |
mass concentrations | 10 |
particle conversion | 10 |
rabies virus | 10 |
small size | 10 |
nt ml | 10 |
previously described | 10 |
infected person | 10 |
inflammasome activation | 10 |
pathogenic microorganisms | 10 |
petri dishes | 10 |
respiratory infection | 10 |
new eulerian | 10 |
amino acids | 10 |
still air | 10 |
bioaerosol concentration | 10 |
interface tension | 10 |
first time | 10 |
diameter cm | 10 |
pathogen transmission | 10 |
bioaerosol material | 10 |
higher concentrations | 10 |
viral supernatants | 10 |
sampling probe | 10 |
simulation results | 10 |
veev tc | 10 |
agar plate | 10 |
norwalk virus | 10 |
image velocimetry | 10 |
nervous system | 10 |
cfd simulation | 10 |
wafer surface | 10 |
herpes simplex | 10 |
dust concentration | 10 |
respiratory pathogens | 9 |
commons licence | 9 |
based vaccine | 9 |
particle orientation | 9 |
total concentration | 9 |
calculation result | 9 |
supplementary material | 9 |
may provide | 9 |
viable microorganisms | 9 |
sampling points | 9 |
small intestine | 9 |
dv supply | 9 |
dental unit | 9 |
gu zhenchao | 9 |
gas flow | 9 |
actual particle | 9 |
physical properties | 9 |
american conference | 9 |
air purification | 9 |
fungal bioaerosol | 9 |
heat source | 9 |
particle properties | 9 |
cleaning system | 9 |
tpi cotton | 9 |
influencing factors | 9 |
flow oxygen | 9 |
osmotic pressure | 9 |
experimental design | 9 |
elongated particles | 9 |
washed three | 9 |
humidity conditions | 9 |
extremely low | 9 |
bioaerosol dynamics | 9 |
nm long | 9 |
another example | 9 |
sulfur dioxide | 9 |
passive sampling | 9 |
time scale | 9 |
particle emission | 9 |
airflow field | 9 |
cells exposed | 9 |
aqueous solution | 9 |
enclosed environments | 9 |
exhaust gases | 9 |
chronic obstructive | 9 |
geometric standard | 9 |
dispersion normalized | 9 |
significant increase | 9 |
microorganisms may | 9 |
collected particles | 9 |
time needed | 9 |
emission rates | 9 |
aerosol size | 9 |
surface morphology | 9 |
critical review | 9 |
particle movement | 9 |
droplets produced | 9 |
cfd code | 9 |
chromatographic purification | 9 |
viral capsid | 9 |
low temperature | 9 |
extraction kit | 9 |
upper limit | 9 |
detailed information | 9 |
diffusional loss | 9 |
air sample | 9 |
lymph node | 9 |
significant decrease | 9 |
cross dimension | 9 |
room without | 9 |
long distances | 9 |
must also | 9 |
gravity orientations | 9 |
multifunctional protein | 9 |
behind bend | 9 |
door opening | 9 |
dane particles | 9 |
transmission electron | 9 |
common cold | 9 |
comparatively large | 9 |
central nervous | 9 |
pc cm | 9 |
plasma membrane | 9 |
purification process | 9 |
air sampler | 9 |
three stages | 9 |
virus replication | 9 |
medical grade | 9 |
volume ratio | 9 |
good agreement | 9 |
next generation | 9 |
forming units | 9 |
table lists | 9 |
since nanoparticles | 9 |
aerosolized influenza | 9 |
viable airborne | 9 |
insect cells | 9 |
vortex rings | 9 |
numerical investigation | 9 |
close contact | 9 |
pseudomonas aeruginosa | 9 |
particles due | 9 |
single particles | 9 |
particle orientations | 9 |
maximum value | 9 |
membrane curvature | 9 |
nasal administration | 9 |
back dvgs | 9 |
spontaneous curvature | 9 |
particle will | 9 |
genomic copies | 9 |
high throughput | 9 |
droplet sizes | 9 |
data set | 9 |
remain airborne | 9 |
significant reduction | 9 |
sizes ranging | 9 |
cascade impactor | 9 |
six stage | 9 |
bending rigidity | 9 |
velocity vector | 9 |
porcine circovirus | 9 |
polluted air | 9 |
samples incubated | 9 |
respiratory deposition | 9 |
velocity increases | 9 |
human astrovirus | 9 |
thermal energy | 9 |
diffusional deposition | 9 |
small particle | 9 |
particle flow | 9 |
cibacron blue | 9 |
healthcare settings | 9 |
velocity distribution | 9 |
density gradient | 9 |
plga nps | 9 |
medical applications | 9 |
droplet dispersion | 9 |
electrostatic charge | 9 |
rna virus | 9 |
large amount | 9 |
version posted | 9 |
standard virus | 9 |
deposition velocities | 9 |
interfering virus | 9 |
microbial species | 9 |
china academy | 9 |
bend outlet | 9 |
statistical analysis | 9 |
decreasing particle | 9 |
human airways | 9 |
various kinds | 9 |
initial velocity | 9 |
decay rate | 9 |
clearly seen | 9 |
dead cells | 9 |
tio particles | 9 |
viral diagnosis | 9 |
protein expression | 9 |
rocket orientation | 9 |
respirable dust | 9 |
specific targeting | 9 |
significantly reduced | 9 |
normal respiration | 9 |
environmental samples | 9 |
psl particles | 9 |
future studies | 9 |
also observed | 9 |
heat wall | 9 |
nm range | 9 |
vaccine containing | 9 |
vacuum pump | 9 |
per litre | 9 |
virus infections | 9 |
icosahedral symmetry | 9 |
tumor cells | 9 |
ventilation scheme | 9 |
vaccine adjuvant | 9 |
fast photography | 9 |
spherical nanoparticles | 9 |
dental aerosols | 9 |
ultrafine particle | 9 |
welding fume | 9 |
infection transmission | 9 |
sampling duration | 9 |
aerosols produced | 9 |
velocity behind | 9 |
standard particles | 9 |
calculation results | 9 |
posted july | 9 |
external force | 9 |
air volume | 8 |
spray dried | 8 |
curved interfaces | 8 |
grid systems | 8 |
mumps virus | 8 |
surrounding interface | 8 |
growth factor | 8 |
trace metal | 8 |
adhesion energy | 8 |
measured concentration | 8 |
mass median | 8 |
equivalent diameter | 8 |
continuum phase | 8 |
nasal cannula | 8 |
important parameter | 8 |
respirator performance | 8 |
finite element | 8 |
particle dynamics | 8 |
processing pathways | 8 |
exhaled aerosol | 8 |
energy barriers | 8 |
surgical team | 8 |
derived virus | 8 |
previous work | 8 |
energy gain | 8 |
generation sequencing | 8 |
care settings | 8 |
phase diagram | 8 |
swine confinement | 8 |
expiratory activities | 8 |
sampling efficiency | 8 |
current work | 8 |
aerosol generating | 8 |
high momentum | 8 |
vertical axis | 8 |
pore sizes | 8 |
fluorescent signals | 8 |
without permission | 8 |
gelatin filters | 8 |
different air | 8 |
stokes number | 8 |
particles must | 8 |
pharmaceutical industry | 8 |
zefon international | 8 |
inflammatory effects | 8 |
heat sources | 8 |
adverse effect | 8 |
gravitational sedimentation | 8 |
air speed | 8 |
mass distribution | 8 |
horizontal sampling | 8 |
give rise | 8 |
transport model | 8 |
atmospheric aerosol | 8 |
antiviral immunity | 8 |
allowed without | 8 |
healthcare environments | 8 |
fluid interface | 8 |
certain particle | 8 |
glass surfaces | 8 |
study showed | 8 |
live attenuated | 8 |
coughing velocity | 8 |
velocity will | 8 |
unpublished observations | 8 |
organic chemicals | 8 |
total deposition | 8 |
house dust | 8 |
flpsl particle | 8 |
one hour | 8 |
significant impact | 8 |
particle contamination | 8 |
rhdv vlp | 8 |
trace amounts | 8 |
viral morphology | 8 |
dvg generation | 8 |
scanning electron | 8 |
respiratory aerosols | 8 |
smaller particle | 8 |
maximum velocity | 8 |
using two | 8 |
air filtration | 8 |
mouse model | 8 |
straight line | 8 |
type virus | 8 |
potentially infectious | 8 |
long time | 8 |
plant viruses | 8 |
bacterial particles | 8 |
developed flow | 8 |
median aerodynamic | 8 |
nonenveloped viruses | 8 |
turbidity measurements | 8 |
short period | 8 |
glutamic acid | 8 |
targeted delivery | 8 |
table shows | 8 |
airborne influenza | 8 |
reuse allowed | 8 |
two groups | 8 |
laser particle | 8 |
particle injection | 8 |
see table | 8 |
virus like | 8 |
relative error | 8 |
recent advances | 8 |
radiological protection | 8 |
two kinds | 8 |
determined using | 8 |
particles onto | 8 |
exhalation simulator | 8 |
toxic effects | 8 |
biological cells | 8 |
microbial community | 8 |
analytical methods | 8 |
mosaic virus | 8 |
personal sampler | 8 |
small fraction | 8 |
infection rate | 8 |
also found | 8 |
indoor particles | 8 |
two approaches | 8 |
governmental industrial | 8 |
investigated using | 8 |
exhaled particle | 8 |
negative air | 8 |
air temperature | 8 |
chemical substances | 8 |
final manuscript | 8 |
viral envelope | 8 |
factors affecting | 8 |
viral antigens | 8 |
data indicate | 8 |
filtration theory | 8 |
significantly affected | 8 |
drug particles | 8 |
hazardous airborne | 8 |
particle suspension | 8 |
small amount | 8 |
also included | 8 |
viral content | 8 |
solar radiation | 8 |
vaccine formulations | 8 |
rate coefficient | 8 |
pollutant concentration | 8 |
peak inhalation | 8 |
silica particles | 8 |
generated using | 8 |
particle incubation | 8 |
target material | 8 |
protein antigens | 8 |
adverse effects | 8 |
may lead | 8 |
horizontal distance | 8 |
protein production | 8 |
transport characteristics | 8 |
second stage | 8 |
time required | 8 |
enclosure line | 8 |
small enough | 8 |
mostly used | 8 |
high air | 8 |
confinement buildings | 8 |
particles seen | 8 |
fluid mechanics | 8 |
two sides | 8 |
short time | 8 |
cbpf plot | 8 |
building envelope | 8 |
dna fragments | 8 |
particles nm | 8 |
hydrophobic interaction | 8 |
toward understanding | 8 |
bioaerosol concentrations | 8 |
mechanical properties | 8 |
oil mist | 8 |
deposition fraction | 8 |
subunit vaccine | 8 |
may occur | 8 |
flow cytometer | 8 |
electrostatic force | 8 |
containing particles | 8 |
aerosol collection | 8 |
turbulent gas | 8 |
calculated result | 8 |
gravitational acceleration | 8 |
dental office | 8 |
affinity baits | 8 |
longer time | 8 |
formulation science | 8 |
volume i | 8 |
inflammatory responses | 8 |
hospital ward | 8 |
ros production | 8 |
filtration resistance | 8 |
fend study | 8 |
several hundred | 8 |
determine whether | 8 |
white blood | 8 |
legionella pneumophila | 8 |
therapeutic protein | 8 |
carbon particles | 8 |
obstructive pulmonary | 8 |
dna damage | 8 |
acinar tree | 8 |
industrial hygienists | 8 |
last years | 8 |
virus surface | 8 |
breathing angle | 8 |
negative control | 8 |
inhaled particles | 8 |
experimental measurements | 8 |
traffic emission | 8 |
negative charge | 8 |
building research | 8 |
laboratory animals | 8 |
molecular diffusion | 8 |
table provides | 8 |
porcine rotavirus | 8 |
boric acid | 8 |
protein monomers | 8 |
significant effect | 8 |
general inpatient | 8 |
optical fibers | 8 |
nuclear localization | 8 |
air cleaners | 8 |
fume hood | 8 |
sample collection | 8 |
two main | 8 |
small number | 8 |
discrete phase | 8 |
flow resistance | 8 |
free energy | 8 |
sirna extracted | 8 |
antibody complexes | 8 |
carbon filter | 8 |
human behavior | 8 |
human volunteers | 8 |
comparative study | 8 |
nvr particles | 8 |
elastic properties | 8 |
tested using | 8 |
morphologically similar | 8 |
nucleation mode | 8 |
leukemia virus | 7 |
microbial volatile | 7 |
viral titer | 7 |
filtration processes | 7 |
diagnostic work | 7 |
whole particle | 7 |
among others | 7 |
results suggest | 7 |
respiratory secretions | 7 |
breath level | 7 |
size bin | 7 |
exchange chromatography | 7 |
viral samples | 7 |
respirable particles | 7 |
vaccine formulation | 7 |
test specimen | 7 |
different flow | 7 |
viral genomic | 7 |
particles carrying | 7 |
extremely small | 7 |
respiratory disease | 7 |
aerosol source | 7 |
monoclonal antibody | 7 |
widely applied | 7 |
reducing airborne | 7 |
aerosol droplets | 7 |
minutes seconds | 7 |
animal species | 7 |
sampling techniques | 7 |
human activity | 7 |
successfully used | 7 |
particulate contaminant | 7 |
virus viability | 7 |
may help | 7 |
tlr agonist | 7 |
exposure time | 7 |
wrapped particles | 7 |
flow solver | 7 |
trapping energy | 7 |
subunit vaccines | 7 |
dioxide laser | 7 |
human nose | 7 |
cell membranes | 7 |
stained particles | 7 |
empty capsids | 7 |
well known | 7 |
will occur | 7 |
coagulation effect | 7 |
retroviral vectors | 7 |
sars coronavirus | 7 |
liquid droplets | 7 |
exit flow | 7 |
inhalation exhalation | 7 |
nanoparticles generated | 7 |
organic matter | 7 |
receptor binding | 7 |
another study | 7 |
also includes | 7 |
neutral ph | 7 |
transmission via | 7 |
median diameter | 7 |
simplified model | 7 |
extensively used | 7 |
particularly important | 7 |
gas clouds | 7 |
infected pigs | 7 |
cfd simulations | 7 |
chemical analysis | 7 |
particle settling | 7 |
natural silk | 7 |
speed air | 7 |
samples containing | 7 |
flow front | 7 |
particle collection | 7 |
ligand density | 7 |
particles deposit | 7 |
sampling system | 7 |
better understand | 7 |
stage impactor | 7 |
cell type | 7 |
new drift | 7 |
common hepa | 7 |
system based | 7 |
ventilation strategies | 7 |
surgical diathermy | 7 |
airborne microorganism | 7 |
associated gastroenteritis | 7 |
harmonic driving | 7 |
fluorescent lamp | 7 |
certain size | 7 |
acid residues | 7 |
vaccines based | 7 |
settling chamber | 7 |
flow direction | 7 |
continuous phase | 7 |
high risk | 7 |
protective breath | 7 |
stain electron | 7 |
layer thickness | 7 |
available beads | 7 |
total particles | 7 |
unipolar ion | 7 |
transport equation | 7 |
individual virus | 7 |
bronchiole flow | 7 |
bilayer membranes | 7 |
human occupants | 7 |
air currents | 7 |
membrane proteins | 7 |
virus vaccine | 7 |
currently available | 7 |
wall interactions | 7 |
performance evaluation | 7 |
human bodies | 7 |
results showed | 7 |
concentration polarization | 7 |
rates indoors | 7 |
capsid shell | 7 |
hydrogel particles | 7 |
lipid bilayers | 7 |
parainfluenza virus | 7 |
exhaust airflow | 7 |
opposite direction | 7 |
traffic nucleation | 7 |
projected area | 7 |
class i | 7 |
invalid layer | 7 |
asbestos fibers | 7 |
viral vaccines | 7 |
indoor concentrations | 7 |
increasing particle | 7 |
guinea pig | 7 |
nasal delivery | 7 |
particle shapes | 7 |
simplex virus | 7 |
retroviral vector | 7 |
newcastle disease | 7 |
biological entities | 7 |
containment device | 7 |
well viral | 7 |
baculovirus expression | 7 |
facepiece respirators | 7 |
absolute humidity | 7 |
results demonstrate | 7 |
satellite viruses | 7 |
airflow patterns | 7 |
air motion | 7 |
static samplers | 7 |
differential equations | 7 |
high level | 7 |
log decrease | 7 |
wastewater treatment | 7 |
process development | 7 |
care facilities | 7 |
stratification height | 7 |
insoluble particles | 7 |
new method | 7 |
tissue particles | 7 |
surface areas | 7 |
higher concentration | 7 |
allowable tube | 7 |
treatment processes | 7 |
health effect | 7 |
vary considerably | 7 |
volume fraction | 7 |
fluorescent dye | 7 |
lymphocytic choriomeningitis | 7 |
protein vector | 7 |
preventive measures | 7 |
droplet transmission | 7 |
enhancement factor | 7 |
bioaerosol exposure | 7 |
interface curvature | 7 |
total pnc | 7 |
key parameters | 7 |
predicting particle | 7 |
local particle | 7 |
biological membranes | 7 |
new sampler | 7 |
genomic rna | 7 |
mechanical stress | 7 |
point source | 7 |
antigen presentation | 7 |
ambient pm | 7 |
volume per | 7 |
droplets may | 7 |
individual particle | 7 |
specific ligands | 7 |
laminar airflow | 7 |
canine parvovirus | 7 |
respiratory pathogen | 7 |
salmonella enterica | 7 |
sample flow | 7 |
particle detector | 7 |
envelope proteins | 7 |
adjuvant effect | 7 |
aerosol generator | 7 |
control measures | 7 |
pollution control | 7 |
unit volume | 7 |
particles increases | 7 |
flow conditions | 7 |
horizontal plane | 7 |
upper concentration | 7 |
rate constant | 7 |
secondary airborne | 7 |
doublet formation | 7 |
dendritic cell | 7 |
dna sequences | 7 |
cell viability | 7 |
dynamic binding | 7 |
generation zone | 7 |
spatial distribution | 7 |
surgical procedure | 7 |
concentration limit | 7 |
surface reactivity | 7 |
diagnostic virology | 7 |
flow pattern | 7 |
particles compared | 7 |
informed consent | 7 |
cell size | 7 |
young children | 7 |
studies using | 7 |
one kind | 7 |
current knowledge | 7 |
medrxiv preprint | 7 |
several hours | 7 |
concentration gradient | 7 |
airborne disease | 7 |
crystal structure | 7 |
since particles | 7 |
stage ionization | 7 |
dioxide particles | 7 |
lagrangian models | 7 |
human exhalation | 7 |
virus purification | 7 |
scattered light | 7 |
dimensionless deposition | 7 |
filter efficiency | 7 |
low flow | 7 |
laser treatment | 7 |
one particle | 7 |
collected using | 7 |
indoor emissions | 7 |
livestock buildings | 7 |
toxicological effects | 7 |
various indoor | 7 |
loaded nps | 7 |
reynolds stress | 7 |
healthy volunteers | 7 |
pressure gradient | 7 |
concentration peak | 7 |
length viral | 7 |
absolute negative | 7 |
penetrating peptides | 7 |
particulate pollutants | 7 |
protein structure | 7 |
enclosed spaces | 7 |
agree well | 7 |
sample size | 7 |
many studies | 7 |
slit lamp | 7 |
real time | 7 |
bioaerosol samples | 7 |
large quantity | 7 |
horizontal axis | 7 |
interface tensions | 7 |
ros generation | 7 |
slit sampler | 7 |
contact transmission | 7 |
particle source | 7 |
collection medium | 7 |
computational domain | 7 |
shaped particles | 7 |
water interface | 7 |
contact lines | 7 |
air pressure | 7 |
buffered saline | 7 |
temperature conditions | 7 |
chikungunya virus | 7 |
delivery vehicles | 7 |
previous section | 7 |
interface deformation | 7 |
cough flow | 7 |
manufacturing process | 7 |
method used | 7 |
data sets | 7 |
nickel compounds | 7 |
papilloma virus | 7 |
parallel flow | 7 |
normal human | 7 |
absorption coefficients | 7 |
particles tend | 7 |
airborne pathogen | 7 |
may reduce | 7 |
cattle houses | 7 |
nacl aerosol | 7 |
deposition ratios | 7 |
highly contaminated | 7 |
european commission | 7 |
intervention techniques | 7 |
composting facilities | 7 |
flow inside | 7 |
return air | 7 |
cells using | 7 |
various particle | 7 |
abiotic particles | 7 |
industrial processes | 7 |
specific antibodies | 7 |
charged sediments | 7 |
fabrics used | 7 |
velocity magnitude | 7 |
particle sampling | 7 |
fwhm ns | 7 |
pollution exposure | 7 |
simple method | 7 |
broad range | 7 |
ii electrostatic | 7 |
membrane filters | 7 |
aspergillus fumigatus | 7 |
cellular responses | 7 |
counting techniques | 7 |
fluid velocity | 7 |
linked immunosorbent | 7 |
diameter smaller | 7 |
obtained using | 7 |
airflow rates | 7 |
clinical practice | 7 |
particles associated | 7 |
growth medium | 7 |
many viruses | 7 |
distribution within | 7 |
blood samples | 7 |
gravity orientation | 7 |
qpcr detection | 7 |
air ion | 7 |
may pose | 7 |
downstream process | 7 |
submarine orientation | 7 |
animal activity | 7 |
antibody responses | 7 |
diameter particles | 7 |
outdoor pm | 7 |
experimental studies | 7 |
antigen delivery | 7 |
flow along | 7 |
gaseous pollutants | 7 |
many particles | 7 |
american society | 7 |
pulmonary region | 7 |
exhaled breaths | 7 |
significantly reduce | 7 |
second air | 7 |
reverse transcription | 7 |
tumor cell | 7 |
intramuscular injection | 7 |
respirable pathogens | 7 |
distribution will | 7 |
inhalable aerosol | 7 |
side orientation | 7 |
vast majority | 7 |
much better | 7 |
inulin adjuvant | 7 |
small interfering | 7 |
generated aerosols | 7 |
nanoparticles may | 7 |
health risks | 7 |
laf systems | 6 |
poorly water | 6 |
will focus | 6 |
number density | 6 |
dna vaccine | 6 |
acid sequence | 6 |
background levels | 6 |
neutralizing antibody | 6 |
one important | 6 |
com scientificreports | 6 |
numerous studies | 6 |
analysis system | 6 |
influenza vlp | 6 |
vertical plane | 6 |
fluorescent particles | 6 |
biologically relevant | 6 |
liquid interfaces | 6 |
solid fraction | 6 |
capture rvfv | 6 |
cubic foot | 6 |
pvc filters | 6 |
lower acini | 6 |
glass fibers | 6 |
heavy oil | 6 |
uranyl acetate | 6 |
shear layer | 6 |
clinical administration | 6 |
polycyclic aromatic | 6 |
spring festival | 6 |
bacillus anthracis | 6 |
specific antibody | 6 |
glial cells | 6 |
particle velocities | 6 |
ultracentrifugal sedimentation | 6 |
human polyomavirus | 6 |
suspended particulate | 6 |
particles exit | 6 |
melting point | 6 |
electrical mobility | 6 |
rich peptides | 6 |
given particle | 6 |
air samplers | 6 |
average number | 6 |
airborne survival | 6 |
mainly used | 6 |
nm wide | 6 |
initial stage | 6 |
counts liter | 6 |
environmental science | 6 |
chemical reactions | 6 |
laboratory diagnosis | 6 |
safety assessment | 6 |
ion generators | 6 |
plant virus | 6 |
particle sensors | 6 |
initial pressure | 6 |
smoothed particle | 6 |
modified lagrangian | 6 |
first one | 6 |
limit values | 6 |
hpv vlp | 6 |
cleaning contam | 6 |
fresh air | 6 |
infectious aerosols | 6 |
barr virus | 6 |
deformations around | 6 |
lung function | 6 |
physical decay | 6 |
one hand | 6 |
dust deposited | 6 |
great importance | 6 |
novel method | 6 |
vaccine immunogenicity | 6 |
nanocomposite particles | 6 |
based methods | 6 |
collects particles | 6 |
ablation yields | 6 |
internal surfaces | 6 |
statistical significance | 6 |
antibody production | 6 |
bulk material | 6 |
time scales | 6 |
unit mass | 6 |
iom sampler | 6 |
peak flow | 6 |
ultraviolet light | 6 |
airborne contaminants | 6 |
measurement results | 6 |
metal fume | 6 |
aggregation rates | 6 |
aromatic hydrocarbons | 6 |
protein design | 6 |
see figures | 6 |
microorganisms collected | 6 |
based samplers | 6 |
adv particle | 6 |
undertaken using | 6 |
typical example | 6 |
first two | 6 |
air stream | 6 |
scale production | 6 |
different environments | 6 |
iom samplers | 6 |
eukaryotic cells | 6 |
lower airways | 6 |
fecal samples | 6 |
vector system | 6 |
pcr assays | 6 |
bimodal distribution | 6 |
aluminum oxide | 6 |
ventilation design | 6 |
air changes | 6 |
derived influenza | 6 |
normalized pmf | 6 |
insoluble nanoparticles | 6 |
increased particle | 6 |
printing mode | 6 |
mixed ventilation | 6 |
urgently needed | 6 |
viral capsids | 6 |
bioaerosol collection | 6 |
particles resulting | 6 |
least one | 6 |
single particle | 6 |
released particles | 6 |
inpatient ward | 6 |
fast emergency | 6 |
polyurethane foam | 6 |
sars virus | 6 |
particle hydrodynamics | 6 |
fine particulate | 6 |
health concern | 6 |
cell receptor | 6 |
important factor | 6 |
starting point | 6 |
successfully captured | 6 |
similar results | 6 |
specific filtration | 6 |
chemical species | 6 |
high humidity | 6 |
significantly lower | 6 |
heilongjiang science | 6 |
mask applied | 6 |
usually present | 6 |
computer simulation | 6 |
exposure system | 6 |
laser desorption | 6 |
nm particle | 6 |
low levels | 6 |
directed evolution | 6 |
immunostimulatory activity | 6 |
reactive oxygen | 6 |
separation strategy | 6 |
potential implications | 6 |
gnotobiotic piglets | 6 |
system indoors | 6 |
human microbiome | 6 |
smoke produced | 6 |
toxicological studies | 6 |
schematic diagram | 6 |
smooth surface | 6 |
multivariate analysis | 6 |
will become | 6 |
manikin head | 6 |
membrane technology | 6 |
aerosolised pathogen | 6 |
closely related | 6 |
compressed air | 6 |
versicolor spores | 6 |
also suggested | 6 |
tilt angle | 6 |
airborne particulate | 6 |
housing system | 6 |
human pathogens | 6 |
molecular counts | 6 |
external harmonic | 6 |
virus protein | 6 |
classroom environment | 6 |
environ doi | 6 |
bioaerosol levels | 6 |
antigenic determinant | 6 |
duct bends | 6 |
room surfaces | 6 |
nanoparticle respiratory | 6 |
heat flux | 6 |
human beings | 6 |
outdoor environments | 6 |
bacterial cell | 6 |
salmonella typhimurium | 6 |
magnetic field | 6 |
throughput screening | 6 |
based vaccines | 6 |
two methods | 6 |
lung fibrosis | 6 |
corona virus | 6 |
confidence level | 6 |
supernatants containing | 6 |
laf panel | 6 |
virus population | 6 |
theoretical calculation | 6 |
binding protein | 6 |
electrocautery procedures | 6 |
rubella virus | 6 |
nasal cavity | 6 |
carbohydrate excipient | 6 |
heat transfer | 6 |
infectious veev | 6 |
specific immune | 6 |
normal probability | 6 |
laser light | 6 |
surgical site | 6 |
magnetic nt | 6 |
acid sequences | 6 |
group showed | 6 |
expiration air | 6 |
near field | 6 |
eulerian models | 6 |
airflow distribution | 6 |
important source | 6 |
per year | 6 |
united kingdom | 6 |
cunningham correction | 6 |
human cough | 6 |
nasal inspiration | 6 |
different regions | 6 |
associated controlled | 6 |
natural decay | 6 |
among different | 6 |
will need | 6 |
paper filter | 6 |
mediated gene | 6 |
respiratory viral | 6 |
two layers | 6 |
microfluidic device | 6 |
trypsin cleavage | 6 |
will continue | 6 |
transmission routes | 6 |
membrane deformations | 6 |
virtual impactors | 6 |
secondary flow | 6 |
precipitin lines | 6 |
big particles | 6 |
source student | 6 |
target pathogen | 6 |
raw material | 6 |
induced breakdown | 6 |
sun yufeng | 6 |
based nanoparticles | 6 |
chromatography purification | 6 |
particles enter | 6 |
aerosol generated | 6 |
clinical study | 6 |
light sheet | 6 |
globally stable | 6 |
radioactive particles | 6 |
varicella zoster | 6 |
particle release | 6 |
generating procedures | 6 |
lyme disease | 6 |
speed centrifugation | 6 |
solid spherical | 6 |
reduce aerosol | 6 |
expiratory aerosols | 6 |
genomic dna | 6 |
simulated moving | 6 |
enteric coronaviruses | 6 |
far larger | 6 |
may contain | 6 |
time point | 6 |
past decade | 6 |
necrosis virus | 6 |
chronic diseases | 6 |
count particles | 6 |
standard curve | 6 |
background aerosol | 6 |
municipal incinerator | 6 |
approximately mg | 6 |
airborne fungal | 6 |
bond energies | 6 |
hospital wards | 6 |
separation process | 6 |
force field | 6 |
microbial payload | 6 |
mobile deployments | 6 |
duct section | 6 |
efficient gene | 6 |
health administration | 6 |
cause pulmonary | 6 |
including pm | 6 |
dispersion control | 6 |
samples using | 6 |
microscopic examination | 6 |
lower part | 6 |
found value | 6 |
responses induced | 6 |
respiratory failure | 6 |
simulation study | 6 |
deposition indoors | 6 |
fecal suspension | 6 |
averaged navier | 6 |
wind speed | 6 |
particularly useful | 6 |
west nile | 6 |
elevated temperatures | 6 |
bending energy | 6 |
envelope disassembly | 6 |
life technologies | 6 |
collecting efficiency | 6 |
momentum respiratory | 6 |
force per | 6 |
purification trains | 6 |
great potential | 6 |
optical fiber | 6 |
wall suction | 6 |
vlps assembled | 6 |
sirna delivery | 6 |
certain value | 6 |
rate increases | 6 |
thin film | 6 |
rated flow | 6 |
cultured cells | 6 |
anomalous transport | 6 |
fluid membranes | 6 |
paper cone | 6 |
virus aerosols | 6 |
complement fixation | 6 |
ambient temperature | 6 |
previously used | 6 |
zonal model | 6 |
studies will | 6 |
alveolar flow | 6 |
calculation method | 6 |
simulation model | 6 |
membrane inclusions | 6 |
lung disease | 6 |
low boiling | 6 |
mtt assay | 6 |
pm concentrations | 6 |
compartment model | 6 |
anisotropic particles | 6 |
draining lymph | 6 |
acute gastroenteritis | 6 |
change rates | 6 |
become one | 6 |
resistant staphylococcus | 6 |
field test | 6 |
threshold concentration | 6 |
arithmetic average | 6 |
numerical calculations | 6 |
yag laser | 6 |
gastrointestinal tract | 6 |
supporting information | 6 |
fine droplets | 6 |
stationary phase | 6 |
two models | 6 |
pulmonary drug | 6 |
surface temperature | 6 |
time series | 6 |
medical masks | 6 |
energy barrier | 6 |
healthcare facilities | 6 |
clean room | 6 |
viral nature | 6 |
operating table | 6 |
turbulent air | 6 |
large volumes | 6 |
important step | 6 |
black bars | 6 |
mortality rates | 6 |
significant role | 6 |
average specific | 6 |
microfluidic particle | 6 |
virtual mass | 6 |
multidisciplinary systematic | 6 |
analyzed using | 6 |
becomes smaller | 6 |
emergency nasal | 6 |
wafer surfaces | 6 |
microbial air | 6 |
human lungs | 6 |
controlling airborne | 6 |
deionized water | 6 |
given size | 6 |
mixing ventilation | 6 |
virus aerosol | 6 |
silicon wafer | 6 |
gene expression | 6 |
antigenic determinants | 6 |
pm mass | 6 |
andersen six | 6 |
microfluidic devices | 6 |
virus challenge | 6 |
serially diluted | 6 |
vice versa | 6 |
large amounts | 6 |
open windows | 6 |
animal models | 6 |
calibration condition | 6 |
eb virus | 6 |
particle systems | 6 |
low particle | 6 |
pt pore | 6 |
duct behind | 6 |
density maps | 6 |
monodisperse particles | 6 |
story buildings | 6 |
rational design | 6 |
post dosing | 6 |
cell debris | 6 |
nylon screens | 6 |
first described | 6 |
sampling pumps | 6 |
high cost | 6 |
competing interests | 6 |
nasal defense | 6 |
low concentration | 6 |
quantitative polymerase | 6 |
different ventilation | 6 |
dust removal | 6 |
airflow dynamics | 6 |
parameter space | 6 |
commercial vlp | 6 |
exhaust air | 6 |
photomechanical effects | 6 |
seven different | 6 |
concentration will | 6 |
unit particle | 6 |
mass transfer | 6 |
source control | 6 |
oral cavity | 6 |
particle flows | 6 |
airborne fungi | 6 |
cleanroom environments | 6 |
modular protein | 6 |
viral capture | 6 |
recent work | 6 |
extremely high | 6 |
carbon monoxide | 6 |
membrane fouling | 6 |
typhimurium lt | 6 |
short side | 6 |
drug tablets | 6 |
reducing transmission | 6 |
laser fluences | 6 |
higher flow | 6 |
diesel engine | 6 |
peak exhalation | 6 |
housing systems | 6 |
different parts | 6 |
endsealing glue | 6 |
selective sampling | 6 |
upper part | 6 |
side length | 6 |
electric strength | 6 |
enveloped virus | 6 |
three kinds | 6 |
noise ratio | 6 |
symptomatic volunteers | 6 |
scale model | 6 |
fulvic acids | 6 |
antigenically distinct | 6 |
pressure drops | 6 |
colony forming | 6 |
specific surface | 6 |
unit membrane | 6 |
pathogen emissions | 6 |
ultrasonic scaling | 6 |
particles become | 6 |
organic solvents | 6 |
antibody response | 6 |
potent adjuvant | 6 |
dimensionless particle | 6 |
will remain | 6 |
borosilicate glass | 6 |
factors involved | 6 |
technology press | 6 |
polyoma virus | 6 |
study found | 6 |
gel precipitin | 6 |
chemical properties | 6 |
transmitted via | 6 |
acn buffer | 6 |
various fabrics | 6 |
significantly different | 6 |
advanced treatment | 6 |
hepatocellular carcinoma | 6 |
light intensity | 6 |
bacterial aerosols | 6 |
outer layer | 6 |
large droplets | 6 |
prolate ellipsoidal | 6 |
fluorescent dyes | 6 |
nuclear targeting | 6 |
will lead | 6 |
malaria parasite | 6 |
rapid diagnosis | 6 |
gene activation | 6 |
analysis methods | 6 |
resistive pulse | 6 |
particle sc | 6 |
fluorescence detection | 6 |
see section | 6 |
standard dust | 6 |
particulate materials | 6 |
mammalian cell | 6 |
viral aerosols | 6 |
sedimentation process | 6 |
polyomavirus particles | 5 |
time delay | 5 |
unit area | 5 |
bioaerosol health | 5 |
culture systems | 5 |
light scatter | 5 |
number size | 5 |
positive results | 5 |
high filtration | 5 |
simple surgical | 5 |
differential pressure | 5 |
hole correction | 5 |
rabbit hemorrhagic | 5 |
final product | 5 |
long axis | 5 |
zeta potential | 5 |
efficient collection | 5 |
microorganisms present | 5 |
murine leukemia | 5 |
pressure distribution | 5 |
also seen | 5 |
fractogel emd | 5 |
virus vlp | 5 |
particle sources | 5 |
scattering counter | 5 |
may influence | 5 |
collecting electrode | 5 |
particle dispersal | 5 |
densonucleosis virus | 5 |
blood flow | 5 |
disease control | 5 |
several times | 5 |
culture medium | 5 |
cesium chloride | 5 |
particles measured | 5 |
fusion proteins | 5 |
microbial cells | 5 |
may produce | 5 |
sodium salt | 5 |
gram negative | 5 |
triplicate wells | 5 |
hela cells | 5 |
low cost | 5 |
particles also | 5 |
well established | 5 |
ambient environment | 5 |
cleaning handbook | 5 |
buoyant density | 5 |
exhaled bioparticles | 5 |
tunable particle | 5 |
inhalation therapy | 5 |
transport mechanism | 5 |
factor receptor | 5 |
hexahedral elements | 5 |
biological systems | 5 |
ellipsoidal particle | 5 |
quality model | 5 |
indoor emission | 5 |
oral health | 5 |
particle captured | 5 |
vapor interface | 5 |
infected patient | 5 |
changes per | 5 |
tat protein | 5 |
much lower | 5 |
magnetic particles | 5 |
large surgical | 5 |
virus shedding | 5 |
affect particle | 5 |
paracrystalline arrays | 5 |
sensor locations | 5 |
seasonal influenza | 5 |
human polyomaviruses | 5 |
flow nasal | 5 |
results shown | 5 |
will deposit | 5 |
diffusion deposition | 5 |
based bioaerosol | 5 |
large size | 5 |
legal unit | 5 |
sufficiently large | 5 |
last two | 5 |
tilted orientation | 5 |
indoor surfaces | 5 |
ftir spectra | 5 |
using unstructured | 5 |
occupational health | 5 |
clearly defined | 5 |
biological properties | 5 |
moving bed | 5 |
pcr system | 5 |
canine faeces | 5 |
cytopathic effects | 5 |
actual separation | 5 |
especially important | 5 |
another limitation | 5 |
peak diameter | 5 |
sampled concentration | 5 |
study investigated | 5 |
lagrangian method | 5 |
cloth sample | 5 |
interface area | 5 |
sem images | 5 |
osmotic shock | 5 |
nanoparticle vaccine | 5 |
microwave digestion | 5 |
mass captured | 5 |
based particle | 5 |
mean free | 5 |
droplet fate | 5 |
like receptors | 5 |
number distribution | 5 |
point pollution | 5 |
npf events | 5 |
vacuum cleaner | 5 |
molecular mechanisms | 5 |
drug administration | 5 |
convective transport | 5 |
predictive toxicological | 5 |
uniformly distributed | 5 |
airborne infectious | 5 |
emission rate | 5 |
swine fever | 5 |
energy delivery | 5 |
virus concentration | 5 |